341 related articles for article (PubMed ID: 15680279)
21. Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma.
Takashima T; Fujiwara Y; Hamaguchi M; Sasaki E; Tominaga K; Watanabe T; Oshitani N; Higuchi K; Arakawa T
Oncol Rep; 2005 Apr; 13(4):601-6. PubMed ID: 15756430
[TBL] [Abstract][Full Text] [Related]
22. Ligands of peroxisome proliferator-activated receptor-gamma increase the generation of vascular endothelial growth factor in vascular smooth muscle cells and in macrophages.
Jozkowicz A; Dulak J; Piatkowska E; Placha W; Dembinska-Kiec A
Acta Biochim Pol; 2000; 47(4):1147-57. PubMed ID: 11996104
[TBL] [Abstract][Full Text] [Related]
23. Dual function of troglitazone in ICAM-1 gene expression in human vascular endothelium.
Chen NG; Han X
Biochem Biophys Res Commun; 2001 Apr; 282(3):717-22. PubMed ID: 11401521
[TBL] [Abstract][Full Text] [Related]
24. Regulation of the interleukin-1 receptor antagonist in THP-1 cells by ligands of the peroxisome proliferator-activated receptor gamma.
Meier CA; Chicheportiche R; Juge-Aubry CE; Dreyer MG; Dayer JM
Cytokine; 2002 Jun; 18(6):320-8. PubMed ID: 12160520
[TBL] [Abstract][Full Text] [Related]
25. Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma.
Inoue M; Itoh H; Tanaka T; Chun TH; Doi K; Fukunaga Y; Sawada N; Yamshita J; Masatsugu K; Saito T; Sakaguchi S; Sone M; Yamahara Ki ; Yurugi T; Nakao K
Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):560-6. PubMed ID: 11304473
[TBL] [Abstract][Full Text] [Related]
26. Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone.
Benson S; Wu J; Padmanabhan S; Kurtz TW; Pershadsingh HA
Am J Hypertens; 2000 Jan; 13(1 Pt 1):74-82. PubMed ID: 10678274
[TBL] [Abstract][Full Text] [Related]
27. Peroxisome-proliferator-activated-receptor gamma (PPARgamma) independent induction of CD36 in THP-1 monocytes by retinoic acid.
Han S; Sidell N
Immunology; 2002 May; 106(1):53-9. PubMed ID: 11972632
[TBL] [Abstract][Full Text] [Related]
28. Synthetic peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone suppress transcription by promoter 3 of the human thromboxane A2 receptor gene in human erythroleukemia cells.
Coyle AT; Kinsella BT
Biochem Pharmacol; 2006 Apr; 71(9):1308-23. PubMed ID: 16499875
[TBL] [Abstract][Full Text] [Related]
29. The effect of activation of peroxisome proliferator-activated receptor gamma (PPARgamma) on human monocyte function: PPARgamma ligands do not inhibit tumor necrosis factor-alpha release in human monocytic cell line THP-1.
Naitoh T; Kitahara M; Tsuruzoe N
Cell Biol Toxicol; 2000; 16(2):131-5. PubMed ID: 10917568
[TBL] [Abstract][Full Text] [Related]
30. Fenofibrate, troglitazone, and 15-deoxy-Delta12,14-prostaglandin J2 close KATP channels and induce insulin secretion.
Shimomura K; Shimizu H; Ikeda M; Okada S; Kakei M; Matsumoto S; Mori M
J Pharmacol Exp Ther; 2004 Sep; 310(3):1273-80. PubMed ID: 15201343
[TBL] [Abstract][Full Text] [Related]
31. Antiinflammatory and antiarteriosclerotic effects of pioglitazone.
Ishibashi M; Egashira K; Hiasa K; Inoue S; Ni W; Zhao Q; Usui M; Kitamoto S; Ichiki T; Takeshita A
Hypertension; 2002 Nov; 40(5):687-93. PubMed ID: 12411463
[TBL] [Abstract][Full Text] [Related]
32. Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells.
Nakashiro KI; Hayashi Y; Kita A; Tamatani T; Chlenski A; Usuda N; Hattori K; Reddy JK; Oyasu R
Am J Pathol; 2001 Aug; 159(2):591-7. PubMed ID: 11485917
[TBL] [Abstract][Full Text] [Related]
33. Troglitazone and 15-deoxy-delta(12,14)-prostaglandin J2 inhibit shear-induced coupling factor 6 release in endothelial cells.
Tomita H; Osanai T; Toki T; Sasaki S; Maeda N; Murakami R; Magota K; Yasujima M; Okumura K
Cardiovasc Res; 2005 Jul; 67(1):134-41. PubMed ID: 15949477
[TBL] [Abstract][Full Text] [Related]
34. PPARgamma activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes.
Pelton PD; Zhou L; Demarest KT; Burris TP
Biochem Biophys Res Commun; 1999 Aug; 261(2):456-8. PubMed ID: 10425206
[TBL] [Abstract][Full Text] [Related]
35. Ligands of peroxisome proliferator-activated receptor-gamma block activation of pancreatic stellate cells.
Masamune A; Kikuta K; Satoh M; Sakai Y; Satoh A; Shimosegawa T
J Biol Chem; 2002 Jan; 277(1):141-7. PubMed ID: 11606585
[TBL] [Abstract][Full Text] [Related]
36. Human multiple myeloma cells express peroxisome proliferator-activated receptor gamma and undergo apoptosis upon exposure to PPARgamma ligands.
Ray DM; Bernstein SH; Phipps RP
Clin Immunol; 2004 Nov; 113(2):203-13. PubMed ID: 15451478
[TBL] [Abstract][Full Text] [Related]
37. 15-deoxy-Delta12,14-prostaglandin J2 inhibits INF-gamma-induced JAK/STAT1 signalling pathway activation and IP-10/CXCL10 expression in mesangial cells.
Panzer U; Zahner G; Wienberg U; Steinmetz OM; Peters A; Turner JE; Paust HJ; Wolf G; Stahl RA; Schneider A
Nephrol Dial Transplant; 2008 Dec; 23(12):3776-85. PubMed ID: 18596134
[TBL] [Abstract][Full Text] [Related]
38. Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells.
Marra F; Efsen E; Romanelli RG; Caligiuri A; Pastacaldi S; Batignani G; Bonacchi A; Caporale R; Laffi G; Pinzani M; Gentilini P
Gastroenterology; 2000 Aug; 119(2):466-78. PubMed ID: 10930382
[TBL] [Abstract][Full Text] [Related]
39. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
Rubin GL; Zhao Y; Kalus AM; Simpson ER
Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
[TBL] [Abstract][Full Text] [Related]
40. Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo.
Xin X; Yang S; Kowalski J; Gerritsen ME
J Biol Chem; 1999 Mar; 274(13):9116-21. PubMed ID: 10085162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]